| Symbol | SERA |
|---|---|
| Name | SERA PROGNOSTICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical Specialities |
| Address | 2749 EAST PARLEYS WAY,SUITE 200, SALT LAKE CITY, Utah, 84109, United States |
| Telephone | +1 801 990-0520 |
| Fax | — |
| — | |
| Website | https://www.seraprognostics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001534969 |
| Description | Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a womans individualized risk of premature birth, preeclampsia, and other pregnancy complications. Additional info from NASDAQ: |
New Form SCHEDULE 13G/A - SERA PROGNOSTICS, INC. <b>Filed:</b> 2026-07-15 <b>AccNo:</b> 0001716774-26-000016 <b>Size:</b> 8 KB
Read morePRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE
Read moreSERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS
Read moreSERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS
Read moreSERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH
Read moreSERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH
Read moreSERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY
Read moreAnderson Dyaarl Lee Jr. 🔴 sold 4.7K shares of SERA PROGNOSTICS, INC. (SERA) at $2.01 Transaction Date: Jun 11, 2026 | Filing ID: 000006
Read moreAerts Austin 🔴 sold 2.0K shares of SERA PROGNOSTICS, INC. (SERA) at $2.01 Transaction Date: Jun 11, 2026 | Filing ID: 000008
Read moreLindgardt Zhenya 🔴 sold 7.0K shares of SERA PROGNOSTICS, INC. (SERA) at $2.01 Transaction Date: Jun 11, 2026 | Filing ID: 000008
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT04301518 | Prematurity Risk Assessment Combined With Clinical Interventions for Improving … | Na | Preterm Labor | Active_Not_Recruiting | 2020-11-06 | 2026-12-30 | ClinicalTrials.gov |
| NCT03530332 | Prediction and Prevention of Preterm Birth (PREVENT-PTB Study) | Na | Preterm Birth | Terminated | 2018-05-14 | 2019-08-30 | ClinicalTrials.gov |
| NCT02787213 | A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor | — | Preterm Birth | Completed | 2016-08-01 | 2019-06-01 | ClinicalTrials.gov |
| NCT01371019 | Proteomic Assessment of Preterm Birth | — | Preterm Birth | Completed | 2011-04-01 | 2015-04-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| PreTRM test | Other | Approved | Preterm Birth | TERMINATED | NCT03530332 |
| Multimodal intervention strategy | Other | Approved | Preterm Labor | ACTIVE_NOT_RECRUITING | NCT04301518 |
| Multimodal intervention strategy | OTHER | Approved | Preterm Labor | ACTIVE_NOT_RECRUITING | NCT04301518 |